UBS Maintains Buy on Plains All American, Raises Price Target to $28
UBS analyst Manav Gupta maintains Plains All American (NASDAQ:PAA) with a Buy and raises the price target from $27 to $28.
Stocks · News reference
Plains GP Holdings Q2 EPS $(0.37) Misses $0.39 Estimate, Sales $17.693B Beat $12.865B Estimate
Plains GP Holdings (NASDAQ:PAGP) reported quarterly losses of $(0.37) per share which missed the analyst consensus estimate of $0.39 by 194.87 percent. This is a 840 percent decrease over earnings of $0.05 per share
Reference Details
Connected Markets
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
- Source
- benzinga
- Observed
- Checked
- Cadence
- Captured once, then retained as an archive reference
- Status
- fresh
Keep reading
Related Headlines
Barclays Maintains Underweight on Plains GP Holdings, Raises Price Target to $24
Barclays analyst Theresa Chen maintains Plains GP Holdings (NASDAQ:PAGP) with a Underweight and raises the price target from $23 to $24.
Mizuho Maintains Outperform on Plains GP Holdings, Raises Price Target to $30
Mizuho analyst Gabriel Moreen maintains Plains GP Holdings (NASDAQ:PAGP) with a Outperform and raises the price target from $27 to $30.
Citigroup Maintains Neutral on Plains GP Holdings, Raises Price Target to $27
Citigroup analyst Spiro Dounis maintains Plains GP Holdings (NASDAQ:PAGP) with a Neutral and raises the price target from $23 to $27.